Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 6
Submit an article Journal homepage
136
Views
9
CrossRef citations to date
0
Altmetric
Original

A pilot study of bendamustine in elderly patients with high-risk MDS and AML

C. Strupp Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany
,
S. Knipp Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany
,
J. Hartmann Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany
,
N. Gattermann Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany
,
R. Haas Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany
&
U. Germing MD Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, GermanyCorrespondence[email protected]
Pages 1161-1166 | Received 04 Feb 2007, Accepted 10 Mar 2007, Published online: 01 Jul 2009

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Massimiliano Palombi, Pasquale Niscola, Andrea Tendas, Malgorzata Monika Trawinska, Laura Scaramucci, Marco Giovannini, Stefano Fratoni, Alessio Perrotti & Paolo de Fabritiis. (2013) Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia in an elderly patient: complete remissions of both diseases by rituximab–bendamustine regimen combined to hypomethylating therapy. Journal of Chemotherapy 25:4, pages 247-249.
Read now
Francis J. Giles$suffix/text()$suffix/text(). (2007) Bendamustine and cloretazine: Alkylators with sharply contrasting activity in AML. Leukemia & Lymphoma 48:6, pages 1064-1066.
Read now

Articles from other publishers (7)

Kathrin Nachtkamp, Josefine Stark, Andrea Kündgen, Thomas Schroeder, Corinna Strupp, Judith Strapatsas, Esther Schuler, Jennifer Kaivers, Aristoteles Giagounidis, Christina Rautenberg, Carlo Aul, Volker Runde, Rainer Haas, Guido Kobbe, Norbert Gattermann & Ulrich Germing. (2021) Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center. Leukemia Research 108, pages 106611.
Crossref
Jack M. Lionberger, John M. Pagel, Vicky K. Sandhu, Hu Xie, Mazyar Shadman, Raya Mawad, Alexandra Boehm, Carol Dean, Kathleen Shannon-Dorcy, Bart L. Scott, Hans Joachim Deeg, Pamela S. Becker, Paul C. Hendrie, Roland B. Walter, Fabiana Ostronoff, Frederick R. Appelbaum & Elihu H. Estey. (2014) Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design. British Journal of Haematology 166:3, pages 375-381.
Crossref
Christelle Chacar, Elias Jabbour, Farhad Ravandi, Gautam Borthakur, Tapan Kadia, Zeev Estrov, Mary Beth Rios, Jorge Cortes & Hagop Kantarjian. (2012) Phase I-II Study of Bendamustine in Patients With Acute Leukemia and High Risk Myelodysplastic Syndrome. Clinical Lymphoma Myeloma and Leukemia 12:3, pages 197-200.
Crossref
Bruce D. Cheson & Mathias J. Rummel. (2009) Bendamustine: Rebirth of an Old Drug. Journal of Clinical Oncology 27:9, pages 1492-1501.
Crossref
Parameswaran Venugopal, Marta Batus & Stephanie A. Gregory. (2008) Acute Myeloid Leukemia in Older Patients: Special Problems and Possible Solutions. Clinical Leukemia 2:4, pages 237-240.
Crossref
Francesco Onida & Miloslav Beran. (2008) Diagnosis and management of chronic myelomonocytic leukemia. Current Hematologic Malignancy Reports 3:1, pages 31-36.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:1, pages 46-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.